S3851651
≥98%(HPLC) , 945755-56-6
Synonym(s):
(2S)-N-[4-[2-[[4-(4-Morpholinyl)phenyl]amino]-4-pyrimidinyl]phenyl]-2-pyrrolidinecarboxamide;(S)-N-(4-(2-(4-Morpholinophenylamino)pyrimidin-4-yl)phenyl)pyrrolidine-2-carboxamide;N-(4-{2-[(4-Morpholin-4-ylphenyl)amino]pyrimidin-4-yl}phenyl)-L-prolinamide
| Pack Size | Price | Stock | Quantity |
| 5MG | RMB720.90 | In Stock |
|
| 25MG | RMB2826.81 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| storage temp. | Store at -20°C |
| solubility | insoluble in EtOH; insoluble in H2O; ≥11.125 mg/mL in DMSO |
| form | solid |
| color | Green to yellow |
| InChIKey | ISOCDPQFIXDIMS-QHCPKHFHSA-N |
| SMILES | O=C(NC1=CC=C(C=C1)C2=NC(NC3=CC=C(C=C3)N4CCOCC4)=NC=C2)[C@H]5NCCC5 |
Description and Uses
XL019 is used in the synthesis of JAK-2 modulators for the treatment of related diseases.
Safety
| Symbol(GHS) |  GHS08 |
| Signal word | Danger |
| Hazard statements | H372 |
| Precautionary statements | P260-P264-P270-P314-P501 |
| target organs | Central nervous system |
| WGK Germany | WGK 3 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
| Hazard Classifications | STOT RE 1 Oral |
